NADPH-Cytochrome P450 Reductase Is Regulated by All- Trans Retinoic Acid and by 1,25-Dihydroxyvitamin D3 in Human Acute Myeloid Leukemia Cells

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Gocek, Elzbieta ^a   Marchwicka, Aleksandra ^a   Bujko, Kamila ^a   Marcinkowska, Ewa ^a  

^a UNIVERSITY OF WROC AW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CD11B ANTIGEN; CD14 ANTIGEN; CYTOCHROME; CYTOCHROME P450 24A1; CYTOCHROME P450 26; CYTOCHROME P450 REDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE FERRIHEMOPROTEIN REDUCTASE; RETINOIC ACID; RETINOIC ACID RECEPTOR; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; DIHYDROXY-VITAMIN D3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; SMALL INTERFERING RNA; VITAMIN D;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME REGULATION; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE FUSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; POR GENE; PROTEIN EXPRESSION; UPREGULATION; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DRUG EFFECTS; GENETICS; GRANULOCYTE; HL 60 CELL LINE; METABOLISM; MONOCYTE; SIGNAL TRANSDUCTION;

CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENE SILENCING; GRANULOCYTES; HL-60 CELLS; HUMANS; MONOCYTES; NADPH-FERRIHEMOPROTEIN REDUCTASE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRETINOIN; VITAMIN D;

EID: 84898670701     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091752     Document Type: Article

References (27)

1. Rhinn M, Dollé P (2012) Retinoic acid signalling during development. Development 139: 843-858
2. Munker R, Norman A, Koeffler H (1986) Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells. J Clin Invest 78: 424-430 (Pubitemid 16074079)
3. Brackman D, Lund-Johansen F, Aarskog D (1995) Expression of cell surface antigens during the differentiation of HL-60 cells induced by 1,25-dihydroxyvitamin D3, retinoic acid and DMSO. Leuk Res 19: 57-64
4. Ross A (2003) Retinoid production and catabolism: role of diet in regulating retinol esterification and retinoic Acid oxidation. J Nutr 133: 291S-296S (Pubitemid 36070621)
5. Pike W, Meyer M, Lee S (2011) The vitamin D receptor: biochemical, molecular, biological, and genomic era investigations. In: Feldman D, Pike J, Adams J, editors. Vitamin D, 3rd Edition: Academic Press. pp. 97-135
6. Thatcher J, Isoherranen N (2009) The role of CYP26 enzymes in retinoic acid clearance. Expert Opin Drug Metab Toxicol 5: 875-886
7. Ray W, Bain G, Yao M, Gottlieb D (1997) CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family. J Biol Chem 272: 18702-18708 (Pubitemid 27318214)
8. Loudig O, Babichuk C, White J, Abu-Abed S, Mueller C, et al. (2000) Cytochrome P450RAI(CYP26) promoter: a distinct composite retinoic acid response element underlies the complex regulation of retinoic acid metabolism. Mol Endocrinol 14: 1483-1497
9. Loudig O, Maclean G, Dore N, Luu L, Petkovich M (2005) Transcriptional cooperativity between distant retinoic acid response elements in regulation of Cyp26A1 inducibility. Biochem J 392: 241-248 (Pubitemid 41689420)
10. Vaisanen S, Dunlop T, Sinkkonen L, Frank C, Carlberg C (2005) Spatiotemporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-Dihydroxyvitamin D3. J Mol Biol 350: 65-77 (Pubitemid 40804732)
11. Ribes V, Otto D, Dickmann L, Schmidt K, Schuhbaur B, et al. (2007) Rescue of cytochrome P450 oxidoreductase (Por) mouse mutants reveals functions in vasculogenesis, brain and limb patterning linked to retinoic acid homeostasis. Dev Biol 303: 66-81
12. Otto D, Henderson C, Carrie D, Davey M, Gundersen T, et al. (2003) Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic acid homeostasis. Mol Cell Biol 23: 6103-6116 (Pubitemid 37013089)
13. Xia C, Panda S, Marohnic C, Martásek P, Masters B, et al. (2011) Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency. Proc Natl Acad Sci U S A 108: 13486-13491
14. Gocek E, Kielbinski M, Baurska H, Haus O, Kutner A, et al. (2010) Different susceptibilities to 1,25-dihydroxyvitamin D3-induced differentiation of AML cells carrying various mutations. Leuk Res 34: 649-657
15. Baurska H, Klopot A, Kielbinski M, Chrobak A, Wijas E, et al. (2011) Structurefunction analysis of vitamin D2 analogs as potential inducers of leukemia differentiation and inhibitors of prostate cancer proliferation. J Steroid Biochem Mol Biol 126: 46-54
16. Gocek E, Marchwicka A, Baurska H, Chrobak A, Marcinkowska E (2012) Opposite regulation of vitamin D receptor by ATRA in AML cells susceptible and resistant to vitamin D-induced differentiation. J Steroid Biochem Mol Biol 132: 220-226
17. Stewart M, Thiel M, Hogg N (1995) Leukocyte integrins. Curr Opin Cell Biol 7: 690-696
18. Simmons D, Tan S, Tenen D, Nicholson-Weller A, Seed B (1989) Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood 73: 284-289 (Pubitemid 19040989)
19. Gocek E, Baurska H, Marchwicka A, Marcinkowska E (2012) Regulation of Leukemic Cell Differentiation through the Vitamin D Receptor at the Levels of Intracellular Signal Transduction, Gene Transcription, and Protein Trafficking and Stability. Leukemia Research and Treatment 2012: 11
20. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, et al. (1991) NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77: 1080-1086
21. Eichelbaum M, Zanger U (2004) P450 mono-oxygenase system. In: Offermanns S, Rosenthal W, editors. Encyclopedic Reference of Molecular Pharmacology: Springer Berlin-Heidelberg. pp. 705-712
22. Loeper J, Descatoire V, Maurice M, Beaune P, Belghiti J, et al. (1993) Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies. Gastroenterology 104: 203-216 (Pubitemid 23040024)
23. Robin M, Descatoire V, Le Roy M, Berson A, Lebreton F, et al. (2000) Vesicular transport of newly synthesized cytochromes P4501A to the outside of rat hepatocyte plasma membranes. J Pharmacol Exp Ther 294: 1063-1069 (Pubitemid 30666860)
24. Schuster I (2011) Cytochromes P450 are essential players in the vitamin D signaling system. Biochim Biophys Acta 1814: 186-199
25. Flück C, Tajima T, Pandey A, Arlt W, Okuhara K, et al. (2004) Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 36: 228-230 (Pubitemid 38282745)
26. Marohnic C, Panda S, McCammon K, Rueff J, Masters B, et al. (2010) Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect. Drug Metab Dispos 38: 332-340
27. Merla G, Howald C, Henrichsen C, Lyle R, Wyss C, et al. (2006) Submicroscopic deletion in patients with Williams-Beuren syndrome influences expression levels of the nonhemizygous flanking genes. Am J Hum Genet.